Literature DB >> 3669703

Protection of ischemic myocardium by exogenous phosphocreatine. I. Morphologic and phosphorus 31-nuclear magnetic resonance studies.

V G Sharov1, V A Saks, V V Kupriyanov, V L Lakomkin, V I Kapelko, S A Javadov.   

Abstract

A phosphorus 31-nuclear magnetic resonance method was used to study the effect of exogenous phosphocreatine on the isolated perfused rat heart. The hearts were chemically arrested by St. Thomas' Hospital solution and made totally ischemic for 35 minutes at 37 degrees C. In the presence of phosphocreatine, 10 mmol/L, during ischemia, almost complete recovery of heart function and phosphocreatine content and 61% recovery of adenosine triphosphate content were observed after 30 minutes of postischemic reperfusion; in the control experiments without phosphocreatine, contractile function, intracellular phosphocreatine, and adenosine triphosphate contents were restored to 33%, 43%, and 26% of their normal values, respectively. Ultrastructural studies with a lanthanum tracer method showed remarkable protection of sarcolemma against ischemic injury by exogenous phosphocreatine at the level of the glycocalyx.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3669703

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  13 in total

1.  Extracellular metabolic energetics can promote cancer progression.

Authors:  Jia Min Loo; Alexis Scherl; Alexander Nguyen; Fung Ying Man; Ethan Weinberg; Zhaoshi Zeng; Leonard Saltz; Philip B Paty; Sohail F Tavazoie
Journal:  Cell       Date:  2015-01-15       Impact factor: 41.582

2.  Participation of calcium ions in the molecular mechanism of cardioprotective action of exogenous phosphocreatine.

Authors:  E A Konorev; N V Medvedeva; I V Jaliashvili; V L Lakomkin; V A Saks
Journal:  Basic Res Cardiol       Date:  1991 Jul-Aug       Impact factor: 17.165

3.  Creatine and phosphocreatine: a review of their use in exercise and sport.

Authors:  J F Clark
Journal:  J Athl Train       Date:  1997-01       Impact factor: 2.860

4.  Synchrotron radiation Fourier-transform infrared and Raman microspectroscopy study showing an increased frequency of creatine inclusions in the rat hippocampal formation following pilocarpine-induced seizures.

Authors:  J Dulinska; Z Setkowicz; K Janeczko; C Sandt; P Dumas; L Uram; K Gzielo-Jurek; J Chwiej
Journal:  Anal Bioanal Chem       Date:  2011-10-29       Impact factor: 4.142

5.  Both creatine and its product phosphocreatine reduce oxidative stress and afford neuroprotection in an in vitro Parkinson's model.

Authors:  Mauricio Peña Cunha; Maria D Martín-de-Saavedra; Alejandro Romero; Javier Egea; Fabiana K Ludka; Carla I Tasca; Marcelo Farina; Ana Lúcia S Rodrigues; Manuela G López
Journal:  ASN Neuro       Date:  2014-11-24       Impact factor: 4.146

Review 6.  Augmentation of Creatine in the Heart.

Authors:  Sevasti Zervou; Hannah J Whittington; Angela J Russell; Craig A Lygate
Journal:  Mini Rev Med Chem       Date:  2016       Impact factor: 3.862

Review 7.  International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine.

Authors:  Richard B Kreider; Douglas S Kalman; Jose Antonio; Tim N Ziegenfuss; Robert Wildman; Rick Collins; Darren G Candow; Susan M Kleiner; Anthony L Almada; Hector L Lopez
Journal:  J Int Soc Sports Nutr       Date:  2017-06-13       Impact factor: 5.150

8.  Phosphocreatine interacts with phospholipids, affects membrane properties and exerts membrane-protective effects.

Authors:  Malgorzata Tokarska-Schlattner; Raquel F Epand; Flurina Meiler; Giorgia Zandomeneghi; Dietbert Neumann; Hans R Widmer; Beat H Meier; Richard M Epand; Valdur Saks; Theo Wallimann; Uwe Schlattner
Journal:  PLoS One       Date:  2012-08-17       Impact factor: 3.240

Review 9.  Creatine kinase in ischemic and inflammatory disorders.

Authors:  David Kitzenberg; Sean P Colgan; Louise E Glover
Journal:  Clin Transl Med       Date:  2016-08-15

Review 10.  The creatine kinase system as a therapeutic target for myocardial ischaemia-reperfusion injury.

Authors:  Fang Cao; Sevasti Zervou; Craig A Lygate
Journal:  Biochem Soc Trans       Date:  2018-09-20       Impact factor: 5.407

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.